Attached files
file | filename |
---|---|
EX-32 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - REGENERON PHARMACEUTICALS, INC. | regn-ex32x06302020x10q.htm |
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC. | regn-ex312x06302020x10q.htm |
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC. | regn-ex311x06302020x10q.htm |
EX-10.4 - PRALUENT CROSS LICENSE AND COMMERCIALIZATON AGREEMENT - REGENERON PHARMACEUTICALS, INC. | regn-ex104x06302020x10q.htm |
EX-10.3 - THIRD AMENDMENT TO AMENDED AND RESTATED SANOFI LICENSE AND COLLABORATION - REGENERON PHARMACEUTICALS, INC. | regn-ex103x06302020x10q.htm |
EX-10.2.1 - AMENDMENT NO.1 TO CREDIT AGREEMENT BY AND BETWEEN REGISTRANT AND GOLDMAN SACHS - REGENERON PHARMACEUTICALS, INC. | regn-ex1021x06302020x1.htm |
Loading Inline Form.
Settings